Chlorhexidine Gluconate (CHG) Wipes Market

Segmented By Product Type (Bath Wipes & Alcohol-based Wipes); By Concentration (0.5% & 2%); By Application (Central Line-Associated Bloodstream Infections, Catheter-Associated Urinary Tract Infections, ); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies); By End Use (Hospitals, Clinics, Ambulatory Surgical Centers) - Global Demand Analysis & Opportunity Outlook 2027

Buy Now
Report ID: 1468 | Published On: Feb 02, 2023
Request Free Sample Copy

Growth Drivers

Rise in Catheter Associated Urinary Tract Infections (CAUTI)

Cather associated urinary tract infections (CAUTI) is the common hospital acquired infection. According to the report by World Health Organization (WHO), CAUTI accounts for approximately 40 percent of all hospital acquired infections. Risk of acquiring catheter associated urinary tract infections enhances with the increase in the duration of stay in a hospital. On account of such factors, it is expected that the demand for wipes or napkins especially for urinary catheterisaton is going to increase over the forecast period.

Rise in Geriatric Population

The risk of acquiring hospital associated infections enhances linearly with increasing age. Older people who are admitted in the hospital for a longer duration of stay are more susceptible to a variety of different infections. Hospital acquired infection such as urinary tract infections and skin related infections are more common to the geriatric population. These infections can be effectively prevented by adopting anti-infection products which includes sterile wipes and tissues. According to World Bank, total geriatric population was 8.482 percent of the overall global population in 2016 which enhanced to 8.696 percent of the total population in the year 2017. This rise in the geriatric population is anticipated to increase the demand of chlorhexidine gluconate wipes which is further expected to support the growth of global chlorhexidine gluconate wipes market over the forecast period.


Side Effects Associated with Chlorhexidine Gluconate Wipes

Chlorhexidine present in chlorhexidine gluconate wipes have several side effects associated with it which includes itching, redness, blistering, swelling, severe skin rash and many more. Some of the severe side effects related to chlorhexidine may be life threatening. These side effects of chlorhexidine are anticpated to have a negative impact on the market.

Chlorhexidine Gluconate (CHG) Wipes Market
Get more information on this report: Request Sample PDF

Market Size and Forecast

The global chlorhexidine gluconate (CHG) wipes market is observing vibrant growth on account of increasing cases of hospital-acquired infections coupled with surgical site infections. Rise in the geriatric population followed by increase in the number of surgical procedures are an important factor which is supporting the growth of the market. Enhancing awareness regarding chlorhexidine gluconate wipes for reducing harmful bacteria’s from the body is also a factor which is expected to propel the growth of the market. Rise in investments in the healthcare sector and highly developed technology are some of the factors which are anticipated to bolster the growth of global chlorhexidine gluconate wipes market over the forecast period.

Chlorhexidine gluconate wipes market is anticipated to record a CAGR of 4.56% over the forecast period. The chlorhexidine gluconate wipes market is expected to showcase a vibrant growth by the end of the forecast period. The market is segmented into distribution channel such as hospital pharmacies, retail pharmacies and online platforms out of which hospital pharmacies are expected to showcase the largest market share on account of increasing cases of hospital related infections and post-operative infections. Hospital acquired infections such as catheter-associated urinary tract infection (CAUTI) and surgical site infections (SSI) are the common infections which are supporting the growth of the market. 

Chlorhexidine Gluconate (CHG) Wipes Market

Get more information on this report: Download Sample PDF

Market Segmentation

Our-in depth analysis of the global chlorhexidine gluconate wipes market includes the following segments:

By Product Type

  • Bath Wipes
  • Alcohol-based Wipes

By Concentration

  • 0.5%
  • 2%

By Application

  • Central Line-Associated Bloodstream Infections
  • Catheter-Associated Urinary Tract Infections
  • Surgical Site Infections
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Platforms

By End Use

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

By Region

On the basis of regional analysis, global chlorhexidine gluconate wipes market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region.

North America is anticpated to dominate the global chlorhexidine gluconate wipes market on the back of rising number of surgical procedures and presence of key market players. Rising investment in the healthcare sector is also anticipated to support the global chlorhexidine gluconate wipes market over the forecast period.

Europe is also expected to have the largest market share on account of rising case of surgical site infections (SSI) coupled with rising geriatric population. Asia Pacific region is expected to be the fastest growing region on the back of large pool of patient population and growing medical facilities.

Global chlorhexidine gluconate wipes market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC,  Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market Growth

    • GAMA Healthcare Ltd
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Carenow Medical Pvt. Ltd
    • Pal International
    • Cardinal Health
    • BD
    • Sage Products LLC
    • 3M
    • Lernapharm Inc. (Canada)
    • Becton
    • Dickinson and Company
    • Other Prominent Players

In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample